Condition: Class I Malocclusion · Sponsor: Cairo University
The goal of this randomized clinical trial is to evaluate the effect of Smile Arc Marginal Ridge Approach (SAMRA) versus MBT chart method for bracket positioning on orthodontic treatment results. The main questions it aims to answer are: Is there a difference in orthodontic treatment results between smile arc marginal ridge approach (SAMRA) and MBT chart method for bracket positioning? Does SAMRA provide more accurate orthodontic results and reduce the number of archwire bendings and brackets repositioning needed during finishing? The investigators will compare Smile Arc Marginal Ridge Approach (SAMRA) with MBT Chart Method (gold standard) to see if SAMRA provides more accurate orthodontic results and reduce the need for archwire bendings and brackets repositioning during finishing. Participants will: * Undergo orthodontic treatment and divided into two groups, Group A (SAMRA) and Group B (MBT Chart Method). * 0.018-inch MBT brackets will be used in both groups. * Follow ups every 1 month will take place to change the archwires after becoming passive. * After leveling and alignment is completed, orthodontic treatment results, number of archwire bendings and brackets repositioning needed will be determined to see which type of intervention is better or if both provide similar results.
This description comes directly from the study's public registry record.
Medhat Mostafa Kamal · +201229235977 · Medhat-Mostafa@dentistry.cu.edu.eg
Always discuss trial participation with your own doctor first.
| Faculty of Dentistry Cairo University | Cairo, Manial, Egypt | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06652230